跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OT 1
首页
药物
OT 1
OT 1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CRYSTALLINE (3Z,5S)-5-(HYDROXYMETHYL)-1-[(2'-METHYL-1,1'-BIPHENYL-4-YL)CARBONYL]PYRROLIDIN-3-ONE O-METHYLOXIME USEFUL IN METHODS OF TREATING CONDITIONS RELATED TO THE OT-R ACTIVITY
EP 3164384 B1
申请人: OBSEVA SA
优先权: 2014
CN
EP
US
WO
10 件公开
benzamide derivatives as oxytocin agonists and vasopressin antagonists
EP 1449844 A1
申请人: FERRING BV
优先权: 2003
EP
US
4 件公开
NOVEL TREATMENT OF MULTIPLE SCLEROSIS (MS)
WO 2012059541 A1
申请人: UNIV JW GOETHE FRANKFURT MAIN
优先权: 2010
CN
WO
2 件公开
CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS
US 2015051183 A1
申请人: POLYPHOR AG
优先权: 2012
CN
US
2 件公开
New indole derivatives and their use as medicine
EP 1939195 A1
申请人: AETERNA ZENTARIS GMBH
优先权: 2001
EP
2 件公开
Fungicidal triazolopyrimidines, process for their preparation, their use for combatting fungi and agents comprising them
EP 1616870 A1
申请人: BASF AG
优先权: 2002
EP
2 件公开
Quinazolines as MMP-13 inhibitors
US 2002193377 A1
申请人: ANDRIANJARA CHARLES
优先权: 2002
US
Pharmaceutically active oligosaccharide conjugates
US 2006100163 A1
申请人: ORLANDO MICHELE
优先权: 2002
US
Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
EP 2332924 A1
申请人: BOEHRINGER INGELHEIM PHARMA
优先权: 2002
EP
4-(N-Phenylamino)-quinazolines/quinolines as inhibitors of tyrosine kinases
EP 2298305 A1
申请人: BOEHRINGER INGELHEIM PHARMA
优先权: 2003
EP
第 1 / 3 页
上一页
下一页
药物
反馈